Research and development of universal influenza vaccines

Microbes and Infection

Volumn 12, Issue 4, 2010, Pages 280-286

  Du, Lanying ^a   Zhou, Yusen ^b   Jiang, Shibo ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

HA; Influenza; M2e; Vaccine

Indexed keywords

CAPSID PROTEIN; DNA VACCINE; FLAGELLIN; HEMAGGLUTININ; HEMAGGLUTININ 2 FUSION PEPTIDE; INFLUENZA VACCINE; INTERLEUKIN 15; M2E PEPTIDE; MEMBRANE PROTEIN; PEPTIDE; PROTEIN M1; RECOMBINANT VACCINE; SIALIDASE; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN;

ADJUVANT THERAPY; AMINO ACID SEQUENCE; ANTIBODY RESPONSE; CELLULAR IMMUNITY; HUMORAL IMMUNITY; IMMUNOGENICITY; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N7; INFLUENZA VIRUS A H9N2; MEDICAL RESEARCH; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SHORT SURVEY; UNINDEXED SEQUENCE; VIRUS LIKE AGENT; VIRUS REPLICATION; VIRUS TRANSMISSION;

BIOMEDICAL RESEARCH; CONSERVED SEQUENCE; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINES, SUBUNIT; VIRAL MATRIX PROTEINS;

ORTHOMYXOVIRIDAE;

EID: 77649274431     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.01.001     Document Type: Short Survey

References (45)

1. Swine influenza A (H1N1) infection in two children - Southern California, March-April 2009. MMWR Morb. Mortal. Wkly. Rep. 58 (2009) 400-402
2. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., de G.M., Burke D.F., Fouchier R.A., Pappas C., puche-Aranda C.M., Lopez-Gatell H., Olivera H., Lopez I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson Jr. P.D., Boxrud D., Sambol A.R., Abid S.H., St G.K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., mmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., and Cox N.J. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325 (2009) 197-201
3. Watts G. A/H1N1 influenza virus: the basics. BMJ 339 (2009) b3046
4. Neumann G., Noda T., and Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459 (2009) 931-939
5. Stevens J., Blixt O., Tumpey T.M., Taubenberger J.K., Paulson J.C., and Wilson I.A. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312 (2006) 404-410
6. Ito T., Gorman O.T., Kawaoka Y., Bean W.J., and Webster R.G. Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. J. Virol. 65 (1991) 5491-5498
7. Pinto L.H., and Lamb R.A. The M2 proton channels of influenza A and B viruses. J. Biol. Chem. 281 (2006) 8997-9000
8. Skorko R., Summers D.F., and Galarza J.M. Influenza A virus in vitro transcription: roles of NS1 and NP proteins in regulating RNA synthesis. Virology 180 (1991) 668-677
9. Ng A.K., Zhang H., Tan K., Li Z., Liu J.H., Chan P.K., Li S.M., Chan W.Y., Au S.W., Joachimiak A., Walz T., Wang J.H., and Shaw P.C. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design. FASEB J. 22 (2008) 3638-3647
10. Johansson B.E., and Brett I.C. Changing perspective on immunization against influenza. Vaccine 25 (2007) 3062-3065
11. Widjaja L., Ilyushina N., Webster R.G., and Webby R.J. Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs. Virology 350 (2006) 137-145
12. Huleatt J.W., Nakaar V., Desai P., Huang Y., Hewitt D., Jacobs A., Tang J., McDonald W., Song L., Evans R.K., Umlauf S., Tussey L., and Powell T.J. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 26 (2008) 201-214
13. Kyriakis C.S., De V.A., Barbe F., Bublot M., and Van R.K. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs. Vaccine 27 (2009) 2258-2264
14. Chen M.W., Cheng T.J., Huang Y., Jan J.T., Ma S.H., Yu A.L., Wong C.H., and Ho D.D. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 13538-13543
15. Kunzi V., Dornseiff M., Horwath J., and Hartmann K. Safe vaccination of children with a virosomal adjuvanted influenza vaccine. Vaccine 27 (2009) 1261-1265
16. Adar Y., Singer Y., Levi R., Tzehoval E., Perk S., Banet-Noach C., Nagar S., Arnon R., and Ben-Yedidia T. A universal epitope-based influenza vaccine and its efficacy against H5N1. Vaccine 27 (2009) 2099-2107
17. Chun S., Li C., Van D.G., Wang J., Farnsworth A., Cui X., Rode H., Cyr T.D., He R., and Li X. Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins. Vaccine 26 (2008) 6068-6076
18. Sugrue R.J., and Hay A.J. Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology 180 (1991) 617-624
19. Holsinger L.J., and Lamb R.A. Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology 183 (1991) 32-43
20. Fiers W., De F.M., Birkett A., Neirynck S., and Min J.W. A 'universal' human influenza A vaccine. Virus Res. 103 (2004) 173-176
21. Tompkins S.M., Zhao Z.S., Lo C.Y., Misplon J.A., Liu T., Ye Z., Hogan R.J., Wu Z., Benton K.A., Tumpey T.M., and Epstein S.L. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg. Infect. Dis. 13 (2007) 426-435
22. Wang Y., Zhou L., Shi H., Xu H., Yao H., Xi X.G., Toyoda T., Wang X., and Wang T. Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells. Biochem. Biophys. Res. Commun. 385 (2009) 118-122
23. Wang R., Song A., Levin J., Dennis D., Zhang N.J., Yoshida H., Koriazova L., Madura L., Shapiro L., Matsumoto A., Yoshida H., Mikayama T., Kubo R.T., Sarawar S., Cheroutre H., and Kato S. Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein. Antiviral Res. 80 (2008) 168-177
24. Fu T.M., Freed D.C., Horton M.S., Fan J., Citron M.P., Joyce J.G., Garsky V.M., Casimiro D.R., Zhao Q., Shiver J.W., and Liang X. Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus. Virology 385 (2009) 218-226
25. De F.M., Martens W., Roose K., Deroo T., Vervalle F., Bentahir M., Vandekerckhove J., Fiers W., and Saelens X. An influenza A vaccine based on tetrameric ectodomain of matrix protein 2. J. Biol. Chem. 283 (2008) 11382-11387
26. Denis J., costa-Ramirez E., Zhao Y., Hamelin M.E., Koukavica I., Baz M., Abed Y., Savard C., Pare C., Lopez M.C., Boivin G., and Leclerc D. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine 26 (2008) 3395-3403
27. Mozdzanowska K., Feng J., Eid M., Kragol G., Cudic M., Otvos Jr. L., and Gerhard W. Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 21 (2003) 2616-2626
28. De F.M., Martens W., Smet A., Schotsaert M., Birkett A., Londono-Arcila P., Fiers W., and Saelens X. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies. Vaccine 26 (2008) 6503-6507
29. Fu T.M., Grimm K.M., Citron M.P., Freed D.C., Fan J., Keller P.M., Shiver J.W., Liang X., and Joyce J.G. Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys. Vaccine 27 (2009) 1440-1447
30. Schotsaert M., De F.M., Fiers W., and Saelens X. Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert. Rev. Vaccines 8 (2009) 499-508
31. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.M., Santelli E., Stec B., Cadwell G., Ali M., Wan H., Murakami A., Yammanuru A., Han T., Cox N.J., Bankston L.A., Donis R.O., Liddington R.C., and Marasco W.A. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16 (2009) 265-273
32. Ekiert D.C., Bhabha G., Elsliger M.A., Friesen R.H., Jongeneelen M., Throsby M., Goudsmit J., and Wilson I.A. Antibody recognition of a highly conserved influenza virus epitope. Science 324 (2009) 246-251
33. Throsby M., van den B.E., Jongeneelen M., Poon L.L., Alard P., Cornelissen L., Bakker A., Cox F., van D.E., Guan Y., Cinatl J., ter M.J., Lasters I., Carsetti R., Peiris M., de K.J., and Goudsmit J. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 3 (2008) e3942
34. Prabhu N., Prabakaran M., Ho H.T., Velumani S., Qiang J., Goutama M., and Kwang J. Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection. J. Virol. 83 (2009) 2553-2562
35. Wang S.F., Chen K.H., Thitithanyanont A., Yao L., Lee Y.M., Chan Y.J., Liu S.J., Chong P., Liu W.T., Huang J.C., and Chen Y.M. Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein. Biochem. Biophys. Res. Commun. 382 (2009) 691-696
36. Veljkovic V., Veljkovic N., Muller C.P., Muller S., Glisic S., Perovic V., and Kohler H. Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control. BMC. Struct. Biol. 9 (2009) 21
37. Du A., Daidoji T., Koma T., Ibrahim M.S., Nakamura S., de Silva U.C., Ueda M., Yang C.S., Yasunaga T., Ikuta K., and Nakaya T. Detection of circulating Asian H5N1 viruses by a newly established monoclonal antibody. Biochem. Biophys. Res. Commun. 378 (2009) 197-202
38. Luo M., Tao P., Li J., Zhou S., Guo D., and Pan Z. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. J. Virol. Methods 154 (2008) 121-127
39. Altstein A.D., Gitelman A.K., Smirnov Y.A., Piskareva L.M., Zakharova L.G., Pashvykina G.V., Shmarov M.M., Zhirnov O.P., Varich N.P., Ilyinskii P.O., and Shneider A.M. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. Arch. Virol. 151 (2006) 921-931
40. Barefoot B.E., Sample C.J., and Ramsburg E.A. Recombinant vesicular stomatitis virus expressing influenza nucleoprotein induces CD8 T-cell responses that enhance antibody-mediated protection after lethal challenge with influenza virus. Clin. Vaccine Immunol. 16 (2009) 488-498
41. Patel A., Tran K., Gray M., Li Y., Ao Z., Yao X., Kobasa D., and Kobinger G.P. Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses. Vaccine 27 (2009) 3083-3089
42. Jimenez G.S., Planchon R., Wei Q., Rusalov D., Geall A., Enas J., Lalor P., Leamy V., Vahle R., Luke C.J., Rolland A., Kaslow D.C., and Smith L.R. Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge. Hum. Vaccin. 3 (2007) 157-164
43. Lalor P.A., Webby R.J., Morrow J., Rusalov D., Kaslow D.C., Rolland A., and Smith L.R. Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus. J. Infect. Dis. 197 (2008) 1643-1652
44. Chen Q., Kuang H., Wang H., Fang F., Yang Z., Zhang Z., Zhang X., and Chen Z. Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus. Virus Genes 38 (2009) 30-38
45. Poon L.L., Leung Y.H., Nicholls J.M., Perera P.Y., Lichy J.H., Yamamoto M., Waldmann T.A., Peiris J.S., and Perera L.P. Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice. J. Immunol. 182 (2009) 3063-3071